about
Niacin in the Treatment of Hyperlipidemias in Light of New Clinical Trials: Has Niacin Lost its Place?Quercetin induces hepatic lipid omega-oxidation and lowers serum lipid levels in miceSerum adiponectin relates to shortened overall survival in men with squamous cell esophageal cancer treated with preoperative concurrent chemoradiotherapy: a pilot studyn-3 PUFA: bioavailability and modulation of adipose tissue function.Fatty acids as biocompounds: their role in human metabolism, health and disease: a review. part 2: fatty acid physiological roles and applications in human health and disease.Pleiotropic effects of niacin: Current possibilities for its clinical use.Chronic pancreatitis and the composition of plasma phosphatidylcholine fatty acids.Hypolipidemic drugs can change the composition of rat brain lipids.The influence of polymorphism of -493G/T MTP gene promoter and metabolic syndrome on lipids, fatty acids and oxidative stress.Fatty Acid Composition of Plasma Phosphatidylcholine Determines Body Fat Parameters in Subjects with Metabolic Syndrome-Related Traits.Dietary polyunsaturated fatty acids and adaptation to chronic hypoxia alter acyl composition of serum and heart lipids.Corn oil versus lard: Metabolic effects of omega-3 fatty acids in mice fed obesogenic diets with different fatty acid composition.Omega-3 phospholipids from fish suppress hepatic steatosis by integrated inhibition of biosynthetic pathways in dietary obese miceEffect of column and software on gas chromatographic determination of fatty acidsHigher content of 18:1 trans fatty acids in subcutaneous fat of persons with coronarographically documented atherosclerosis of the coronary arteriesSeverity of metabolic syndrome unfavorably influences oxidative stress and fatty acid metabolism in menAntioxidant status and oxidative stress markers in pancreatic cancer and chronic pancreatitisPlasma fatty acid composition in patients with pancreatic cancer: correlations to clinical parameters
P50
Q26799534-916D6F17-97A2-4FE4-A439-0F963FE24C33Q34566467-4677D774-ED47-422E-B1E6-8560EA3B5F34Q34584928-3C4FDA2E-BCCF-4D7C-917C-6486D21B4742Q37583969-14AF0643-4964-40E4-8158-4BC58D3B3468Q37979687-18DA5C7A-622A-4D00-B13A-AD85A7ABE676Q38810790-54217397-489A-4CAF-AA01-52E8D11893EFQ39787343-4B796AA1-8E55-4BBE-ADCB-896DB4465F72Q45169031-C76EBC10-53BD-4F2D-9E80-B5804FF25B26Q46749686-5394F86E-8EE3-4F04-9EA7-F8A7912BDC5AQ53152255-3EA80E54-45E5-4CBF-9E56-E1BC7C983704Q53392304-EFBB6135-6CEA-40EC-972B-48A52E9DEF05Q53436938-05766BBD-32F5-4745-B17F-7DBB7F045CE7Q59607817-A3D08D46-A09D-4E00-9B1D-6B4A33309E11Q74106575-43E6678A-DE4F-4741-A905-D3746C84EEF5Q79102467-B98180E8-FCA9-46A1-9E20-031642DDABD6Q80694388-3C31335E-E700-433D-BED0-09C644B04C1FQ86543225-45CDE731-CBE8-4C34-9E6E-54CD49EC3B59Q87436709-B32311EC-C2EF-4CEB-BAC1-6B98476F32C8
P50
description
biochemička, klinika gastroenterologie a hepatologie
@cs
onderzoeker
@nl
researcher ORCID ID = 0000-0002-6184-4878
@en
name
Barbora Stankova
@ast
Barbora Stankova
@es
Barbora Stankova
@nl
Barbora Staňková
@cs
Barbora Staňková
@en
type
label
Barbora Stankova
@ast
Barbora Stankova
@es
Barbora Stankova
@nl
Barbora Staňková
@cs
Barbora Staňková
@en
prefLabel
Barbora Stankova
@ast
Barbora Stankova
@es
Barbora Stankova
@nl
Barbora Staňková
@cs
Barbora Staňková
@en
P214
P1153
6602649991
P21
P214
P31
P496
0000-0002-6184-4878